Cargando…

Cofactor-mediated amyloidogenesis

A recent study published in Bioscience Reports by Sheng et al. (Bioscience Reports, (2019) 39, pii:BSR20182345] described a small but significant conformational change that occurs upon zinc binding and results in initiation of the amyloidogenic aggregation cascade of Golgi-Associated plant Pathogene...

Descripción completa

Detalles Bibliográficos
Autor principal: Madine, Jillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400789/
https://www.ncbi.nlm.nih.gov/pubmed/30814314
http://dx.doi.org/10.1042/BSR20190327
_version_ 1783400016566550528
author Madine, Jillian
author_facet Madine, Jillian
author_sort Madine, Jillian
collection PubMed
description A recent study published in Bioscience Reports by Sheng et al. (Bioscience Reports, (2019) 39, pii:BSR20182345] described a small but significant conformational change that occurs upon zinc binding and results in initiation of the amyloidogenic aggregation cascade of Golgi-Associated plant Pathogenesis Related protein 1 (GAPR-1) in the presence of heparin. The present study describes a two-stage process that is required for the initiation of the amyloidogenic aggregation cascade involving a concentration step and a conformation change to enhance accessibility of natively protected amyloidogenic regions for self-association. For GAPR-1 in the present study, these steps are provided by zinc binding causing the required conformational change enhancing accessibility of amyloidogenic regions, and heparin providing a template or scaffold in turn increasing the local protein concentration. Cofactors such as glycosaminoglycans and metal ions have been found associated with amyloid deposits in vivo and shown to affect protein assembly kinetics in vitro. Cofactor interactions with the amyloidogenic process are an area of great interest for therapeutic intervention for the wide range of diseases known to be associated with amyloid protein aggregation. The present study emphasises the need for enhanced structural understanding of cofactor–amyloid protein interactions and highlights that small subtle conformational changes can have large impacts on resulting aggregation processes.
format Online
Article
Text
id pubmed-6400789
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-64007892019-03-09 Cofactor-mediated amyloidogenesis Madine, Jillian Biosci Rep Commentaries A recent study published in Bioscience Reports by Sheng et al. (Bioscience Reports, (2019) 39, pii:BSR20182345] described a small but significant conformational change that occurs upon zinc binding and results in initiation of the amyloidogenic aggregation cascade of Golgi-Associated plant Pathogenesis Related protein 1 (GAPR-1) in the presence of heparin. The present study describes a two-stage process that is required for the initiation of the amyloidogenic aggregation cascade involving a concentration step and a conformation change to enhance accessibility of natively protected amyloidogenic regions for self-association. For GAPR-1 in the present study, these steps are provided by zinc binding causing the required conformational change enhancing accessibility of amyloidogenic regions, and heparin providing a template or scaffold in turn increasing the local protein concentration. Cofactors such as glycosaminoglycans and metal ions have been found associated with amyloid deposits in vivo and shown to affect protein assembly kinetics in vitro. Cofactor interactions with the amyloidogenic process are an area of great interest for therapeutic intervention for the wide range of diseases known to be associated with amyloid protein aggregation. The present study emphasises the need for enhanced structural understanding of cofactor–amyloid protein interactions and highlights that small subtle conformational changes can have large impacts on resulting aggregation processes. Portland Press Ltd. 2019-03-06 /pmc/articles/PMC6400789/ /pubmed/30814314 http://dx.doi.org/10.1042/BSR20190327 Text en © 2019 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentaries
Madine, Jillian
Cofactor-mediated amyloidogenesis
title Cofactor-mediated amyloidogenesis
title_full Cofactor-mediated amyloidogenesis
title_fullStr Cofactor-mediated amyloidogenesis
title_full_unstemmed Cofactor-mediated amyloidogenesis
title_short Cofactor-mediated amyloidogenesis
title_sort cofactor-mediated amyloidogenesis
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400789/
https://www.ncbi.nlm.nih.gov/pubmed/30814314
http://dx.doi.org/10.1042/BSR20190327
work_keys_str_mv AT madinejillian cofactormediatedamyloidogenesis